Provision (credit) for bad debts
McKesson·Business Segments·1 segment
Breakdown
| Segment | Q3 '24 |
|---|---|
| North American Pharmaceutical | -$203.00M |
| Total | -$203.00M |
Segments
North American PharmaceuticalView metric
| Segment | Q3 '24 |
|---|---|
| North American Pharmaceutical | -$203.00M |
| Total | -$203.00M |